4processed
Form 4 — Insider Transaction
Dianthus Therapeutics, Inc. /DE/(DNTH)
Filing Date
June 1, 2026
Accepted
June 1, 2026
Accession No.
0001992260-26-000006
CIK
0001690585
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Randhawa Simrat | EVP, Head of R&D | Other | 4.0K | $8.44 | — | 8.0K | Common Stock | Jun 1, 2026 |
| Randhawa Simrat | EVP, Head of R&D | Other | 6.9K | $17.88 | — | 14.9K | Common Stock | Jun 1, 2026 |
| Randhawa Simrat | EVP, Head of R&D | Other | 6.2K | $21.77 | — | 21.2K | Common Stock | Jun 1, 2026 |
| Randhawa Simrat | EVP, Head of R&D | Other | 9.4K | $22.07 | — | 30.5K | Common Stock | Jun 1, 2026 |
| Randhawa Simrat | EVP, Head of R&D | Other | 5.4K | $89.72 | — | 25.1K | Common Stock | Jun 1, 2026 |
| Randhawa Simrat | EVP, Head of R&D | Other | 16.9K | $90.72 | — | 8.2K | Common Stock | Jun 1, 2026 |
| Randhawa Simrat | EVP, Head of R&D | Other | 4.2K | $91.37 | — | 4.0K | Common Stock | Jun 1, 2026 |
| Randhawa Simrat | EVP, Head of R&D | Other | 4.0K | $0 | — | 0 | Stock Option (Right to Buy) | Jun 1, 2026 |
| Randhawa Simrat | EVP, Head of R&D | Other | 6.9K | $0 | — | 64.3K | Stock Option (Right to Buy) | Jun 1, 2026 |
| Randhawa Simrat | EVP, Head of R&D | Other | 6.2K | $0 | — | 47.9K | Stock Option (Right to Buy) | Jun 1, 2026 |
| Randhawa Simrat | EVP, Head of R&D | Other | 9.4K | $0 | — | 96.9K | Stock Option (Right to Buy) | Jun 1, 2026 |